TrivarX Limited (ASX:TRI)

Australia · Delayed Price · Currency is AUD

0.0100

0.00 (0.00%)

At close: Nov 6, 2026

Market Cap	11.54M -25.8%
Revenue (ttm)	n/a
Net Income	-8.76M
EPS	-0.01
Shares Out	1.15B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,375,736
Open	0.0100
Previous Close	n/a
Day's Range	0.0100 - 0.0100
52-Week Range	0.0070 - 0.0310
Beta	1.06
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 24, 2026

About TrivarX

TrivarX Limited, a biotechnology company, engages in the development of AI-driven, and scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. It is also involved in research, development, and commercialisation of diagnostic and pharmaceutical products. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Hawthorn East, Australia. [Read more]

Industry Health Information Services

Sector Healthcare

Founded 1987

Employees 6

Stock Exchange Australian Securities Exchange

Ticker Symbol TRI

Full Company Profile

Financial Performance

Financial Statements